Merck and Eisai Announce Promising Interim Results from LEAP-015 Trial of KEYTRUDA® and LENVIMA® in HER2-Negative Gastroesophageal Adenocarcinoma

 Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai announced results from the Phase 3 LEAP-015 trial evaluating KEYTR...

January 27, 2025 | Monday | News
Pfizer's BRAFTOVI® Combination Therapy Demonstrates Significant Clinical Benefit in Metastatic Colorectal Cancer with BRAF V600E Mutation

 Pfizer Inc. (NYSE: PFE) announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination ...

January 27, 2025 | Monday | News
Abyssinia Biosciences and Cordance Medical Partner to Explore Focused Ultrasound for Alzheimer's Diagnosis and Treatment

Abyssinia Biosciences and Cordance Medical announced  that they have entered into a collaborative agreement to explore focused ultrasound in diagnosti...

January 24, 2025 | Friday | News
CG Pharmaceuticals Presents Promising Results for Ivaltinostat in Metastatic Pancreatic Cancer at ASCO GI Symposium

CG Pharmaceuticals (CG Pharma), a clinical biopharmaceutical company located in the San Francisco Bay Area, was established as an independent entity i...

January 24, 2025 | Friday | News
Biogen's Higher Dose Regimen of Nusinersen for SMA Receives FDA and EMA Review

Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Applicati...

January 24, 2025 | Friday | News
AbbVie and Neomorph Forge Partnership to Develop Novel Molecular Glue Degraders for Oncology and Immunology

AbbVie (NYSE: ABBV) and Neomorph, Inc. announced a collaboration and option-to-license agreement to develop novel molecular glue degraders for multiple tar...

January 24, 2025 | Friday | News
Disc Medicine Announces Upsized $225.5 Million Public Offering of Common Stock and Pre-Funded Warrants

Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel...

January 23, 2025 | Thursday | News
Roche Receives FDA 510(k) Clearance and CLIA Waiver for Cobas® Liat STI Multiplex Assay Panels

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvem...

January 23, 2025 | Thursday | News
Catalent and Galapagos Partner to Advance Decentralized Manufacturing of CAR-T Therapy for Aggressive Non-Hodgkin Lymphoma

Catalent, Inc., a leader in enabling the development and supply of better treatments for patients worldwide, today announced a strategic collaboration wi...

January 22, 2025 | Wednesday | News
Beckman Coulter Life Sciences and Indiana University Secure $2.5M Grant to Boost Leukemia and Lymphoma Testing in Kenya

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, along with the Indiana University School of Medicine, have been a...

January 22, 2025 | Wednesday | News
Sartorius Powers New Biomanufacturing Lab at McMaster University

  Extended Collaboration with Sartorius Powers New Biomanufacturing Lab at McMaster University, Canada   State-of-the-art bioprocessing au...

January 22, 2025 | Wednesday | News
ALX Oncology to Host Virtual Event on Updated Data from ASPEN-06 Trial of Evorpacept in HER2-Positive Advanced Gastric Cancer

ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing ther...

January 23, 2025 | Thursday | News
Gilead Receives FDA Approval for Yescarta® Label Update, Showing Significant Overall Survival Benefit in Second-Line Treatment for Large B-Cell Lymphoma

Kite, a Gilead Company (Nasdaq: GILD), announced that the U.S. Food and Drug Administration (FDA) has approved a label update for Yescarta® (axica...

January 23, 2025 | Thursday | News
Trump Administration Takes Bold Step to Withdraw U.S. from World Health Organization

  President Donald J. Trump has signed an executive order initiating the withdrawal of the United States from the World Health Organization (WHO). Th...

January 21, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close